Sean Kim
Stock Analyst at JonesTrading
(1.21)
# 1,538
Out of 4,416 analysts
8
Total ratings
28.57%
Success rate
-8.42%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRRX DURECT | Downgrades: Hold | n/a | $1.16 | - | 2 | Nov 9, 2023 | |
| ARQT Arcutis Biotherapeutics | Downgrades: Hold | n/a | $8.60 | - | 2 | Nov 8, 2023 | |
| CLSD Clearside Biomedical | Initiates: Buy | $6 | $1.31 | +358.02% | 1 | Jun 14, 2023 | |
| OVID Ovid Therapeutics | Initiates: Buy | $6 | $3.06 | +96.08% | 1 | Jun 14, 2023 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $26 | $19.74 | +31.71% | 1 | Jun 14, 2023 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $7 | $3.02 | +131.79% | 1 | Mar 14, 2023 |
DURECT
Nov 9, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.16
Upside: -
Arcutis Biotherapeutics
Nov 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $8.60
Upside: -
Clearside Biomedical
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $1.31
Upside: +358.02%
Ovid Therapeutics
Jun 14, 2023
Initiates: Buy
Price Target: $6
Current: $3.06
Upside: +96.08%
EyePoint Pharmaceuticals
Jun 14, 2023
Initiates: Buy
Price Target: $26
Current: $19.74
Upside: +31.71%
Trevi Therapeutics
Mar 14, 2023
Initiates: Buy
Price Target: $7
Current: $3.02
Upside: +131.79%